Malignant Nodular hidradenoma is an extremely rare aggressive tumour originating from eccrine sweat glands with an incidence of <.001%. So far less than 80 cases have been reported in the literature. It’s known for its local recurrence (50%) and metastasis (60%) and hence early diagnosis and radical treatment is mandatory. But differentiating it from its benign counterparts and other skin tumour mimics is challenging, due to its histopathological similarity & lack of diagnostic immunomarkers. Authors report a case of 65-year-old female who presented with a short 4-month history of rapidly growing ulceroproliferative growth in the right inguinal region with bilateral inguinal node enlargement, associated with pain and discharge. Wedge...
BACKGROUND: Eccrine porocarcinoma, first described in 1963, is a rare malignant lesion arising from ...
Background: Nowadays, the incidence of skin cancer has increased, especially in the elderly populati...
International audienceBACKGROUND: To the best of our knowledge, only 52 cases of squamous cell carci...
Hidradenocarcinoma is a rare and locally aggressive tumor rendering a poor prognosis. Furthermore, v...
PubMed ID: 26606241Background: Nodular hidradenoma is an uncommon, benign, adnexal neoplasm of apocr...
Malignant clear cell hidradenoma is an uncommon tumor of eccrine sweat gland origin. In contrast to ...
An apocrine hidradenoma is a benign adnexal neoplasm, usually covered by intact skin, but may show s...
Introduction: Squamoid eccrine carcinoma is a very rare carcinoma with few reported cases in the lit...
Introduction: Hidradenocarcinoma is a rare aggressive tumor arising from sweat glands that may occur...
Nodular hidradenoma is a rare benign skin adnexial lesion of the breast. It is often located in the ...
Hidradenomas are the benign cutaneous tumors of sweat gland origin, with the clear cell type constit...
International audienceCutaneous clear cell hidradenoma is an uncommon benign adnexal tumor which is ...
We present a case of a 64-year-old man who presented with a rapidly growing tumor in the left buttoc...
Melanoma is responsible for 1% to 2% of all cancer deaths around the world. Nodular melanoma often c...
powered view of mass showing well-circumscribed tumor and pseudoencapsulation (top right). Medium-po...
BACKGROUND: Eccrine porocarcinoma, first described in 1963, is a rare malignant lesion arising from ...
Background: Nowadays, the incidence of skin cancer has increased, especially in the elderly populati...
International audienceBACKGROUND: To the best of our knowledge, only 52 cases of squamous cell carci...
Hidradenocarcinoma is a rare and locally aggressive tumor rendering a poor prognosis. Furthermore, v...
PubMed ID: 26606241Background: Nodular hidradenoma is an uncommon, benign, adnexal neoplasm of apocr...
Malignant clear cell hidradenoma is an uncommon tumor of eccrine sweat gland origin. In contrast to ...
An apocrine hidradenoma is a benign adnexal neoplasm, usually covered by intact skin, but may show s...
Introduction: Squamoid eccrine carcinoma is a very rare carcinoma with few reported cases in the lit...
Introduction: Hidradenocarcinoma is a rare aggressive tumor arising from sweat glands that may occur...
Nodular hidradenoma is a rare benign skin adnexial lesion of the breast. It is often located in the ...
Hidradenomas are the benign cutaneous tumors of sweat gland origin, with the clear cell type constit...
International audienceCutaneous clear cell hidradenoma is an uncommon benign adnexal tumor which is ...
We present a case of a 64-year-old man who presented with a rapidly growing tumor in the left buttoc...
Melanoma is responsible for 1% to 2% of all cancer deaths around the world. Nodular melanoma often c...
powered view of mass showing well-circumscribed tumor and pseudoencapsulation (top right). Medium-po...
BACKGROUND: Eccrine porocarcinoma, first described in 1963, is a rare malignant lesion arising from ...
Background: Nowadays, the incidence of skin cancer has increased, especially in the elderly populati...
International audienceBACKGROUND: To the best of our knowledge, only 52 cases of squamous cell carci...